Ladder-like targeted and gated doxorubicin delivery using bivalent aptamer in vitro and in vivo

被引:9
作者
Charbgoo, Fahimeh [1 ,2 ]
Soltani, Fatemeh [3 ]
Alibolandi, Mona [1 ]
Taghdisi, Seyed Mohammad [4 ]
Abnous, Khalil [1 ,5 ]
Ramezani, Pouria [1 ]
Ramezani, Mohammad [1 ,3 ]
机构
[1] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
[2] DWI Leibniz Inst Interact Mat, Forckenbeckstr 50, D-52056 Aachen, Germany
[3] Mashhad Univ Med Sci, Dept Pharmaceut Biotechnol, Sch Pharm, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Targeted Drug Delivery Res Ctr, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Razavi Khorasan, Iran
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2021年 / 119卷 / 119期
基金
美国国家科学基金会;
关键词
Smart delivery; Mesoporous silica; Bivalent aptamer; Bio-blocks; MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; MICELLES; THERAPY;
D O I
10.1016/j.msec.2020.111618
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Regarding side effects of commonly used chemotherapeutic drugs on normal tissues, researchers introduced smart delivery and on-demand release systems. Herein, we applied a bivalent aptamer composed of ATP and AS1411 aptamers for separate targeting and gating of mesoporous silica nanoparticles in a ladder like structure with one bifunctional molecule. First part of the apatmer, AS1411, direct the delivery system to the desired site while the second part, ATP aptamer, opens the pores and release the drug just after penetrance to the cytoplasm ensuring delivery of DOX into the tumor cells. This approach faced the previous challenge of coincident targeting and gating with one aptamer. Our results demonstrated that the proposed nano-system remarkably accumulated in cancer tissue and released the drug in a sustained pattern in cancer cells. It was notably effective for inducing apoptosis in cancer cells and tumor growth inhibition without any significant side effect on normal cells and organs. Moreover, Si-cs-DOX-AAapt improved the mice survival time compared with free doxorubicin and there was no significant change in weight of mice administered with the targeted formulation. This report may open new insight for providing smart delivery systems for successful cancer treatment by introducing separate gating and targeting property by a bivalent aptamer to increase the control over drug release.
引用
收藏
页数:12
相关论文
共 39 条
[1]   Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation [J].
Alibolandi, Mona ;
Abnous, Khalil ;
Mohammadi, Marzieh ;
Hadizadeh, Farzin ;
Sadeghi, Fatemeh ;
Taghavi, Sahar ;
Jaafari, Mahmoud Reza ;
Ramezani, Mohammad .
JOURNAL OF CONTROLLED RELEASE, 2017, 264 :228-236
[2]   Aptamer-Functionalized Silica Nanoparticles for Targeted Cancer Therapy [J].
Aravind, Athulya ;
Veeranarayanan, Srivani ;
Poulose, Aby Cheruvathoor ;
Nair, Remya ;
Nagaoka, Yutaka ;
Yoshida, Yasuhiko ;
Maekawa, Toru ;
Kumar, D. Sakthi .
BioNanoScience, 2012, 2 (01) :1-8
[3]   Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma [J].
Arranz-Romera, A. ;
Davis, B. M. ;
Bravo-Osuna, I ;
Esteban-Perez, S. ;
Molina-Martinez, I. T. ;
Shamsher, E. ;
Ravindran, N. ;
Guo, L. ;
Cordeiro, M. F. ;
Herrero-Vanrell, R. .
JOURNAL OF CONTROLLED RELEASE, 2019, 297 :26-38
[4]   Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma [J].
Babaei, Maryam ;
Abnous, Khalil ;
Taghdisi, Seyed Mohammad ;
Farzad, Sara Amel ;
Peivandi, Mohammad Taghi ;
Ramezani, Mohammad ;
Alibolandi, Mona .
NANOMEDICINE, 2017, 12 (11) :1261-1279
[5]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[6]   Aptamer-Gated Nanoparticles for Smart Drug Delivery [J].
Cengiz Ozalp, Veli ;
Eyidogan, Fusun ;
Oktem, Huseyin Avni .
PHARMACEUTICALS, 2011, 4 (08) :1137-1157
[7]   MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide [J].
Charbgoo, Fahimeh ;
Alibolandi, Mona ;
Taghdisi, Seyed Mohammad ;
Abnous, Khalil ;
Soltani, Fatemeh ;
Ramezani, Mohammad .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (03) :685-697
[8]   Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics [J].
Dogra, Prashant ;
Adolphi, Natalie L. ;
Wang, Zhihui ;
Lin, Yu-Shen ;
Butler, Kimberly S. ;
Durfee, Paul N. ;
Croissant, Jonas G. ;
Noureddine, Achraf ;
Coker, Eric N. ;
Bearer, Elaine L. ;
Cristini, Vittorio ;
Brinker, C. Jeffrey .
NATURE COMMUNICATIONS, 2018, 9
[9]   Targeting inflammasome by the inhibition of caspase-1 activity using capped mesoporous silica nanoparticles [J].
Garcia-Fernandez, Alba ;
Garcia-Lainez, Guillermo ;
Ferrandiz, Maria Luisa ;
Aznar, Elena ;
Sancenon, Felix ;
Alcaraz, Maria Jose ;
Murguia, Jose Ramon ;
Marcos, Maria D. ;
Martinez-Manez, Ramon ;
Costero, Ana M. ;
Orzaez, Mar .
JOURNAL OF CONTROLLED RELEASE, 2017, 248 :60-70
[10]   MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells [J].
Hanafi-Bojd, Mohammad Yahya ;
Kalat, Seyedeh Alia Moosavian ;
Taghdisi, Seyed Mohammad ;
Ansari, Legha ;
Abnous, Khalil ;
Malaekeh-Nikouei, Bizhan .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (01) :13-18